Pillai Arun Kumar

CIK 00017174371 companyBANGALORE, K7

SEC Profile

Transactions

Companies

Filings

CIK

0001717437

Recent Transactions

46 trades

Other
Outlook Therapeutics, Inc.$OTLK
Common Stock
2022-02-01$1.25/sh−2,500,000→ 22,982,529 total
Exercise/Conversion
Outlook Therapeutics, Inc.$OTLK
Common Stock
2020-03-23+29,358,621→ 50,965,058 total
Exercise/Conversion
Outlook Therapeutics, Inc.$OTLK
Series A-1 Convertible Preferred Stock
2020-03-23−68,112→ 0 total
Award
Outlook Therapeutics, Inc.$OTLK
Series A-1 Convertible Preferred Stock
2020-03-19+68,112→ 68,112 total
Disposition to Issuer
Outlook Therapeutics, Inc.$OTLK
Series A-1 Convertible Preferred Stock
2020-03-19−68,112→ 0 total
Exercise/Conversion
Outlook Therapeutics, Inc.$OTLK
Common Stock
2020-01-29$0.23/sh+4,657,852→ 21,606,437 total
Exercise/Conversion
Outlook Therapeutics, Inc.$OTLK
Warrant (Right to Buy)
2020-01-29−2,093,750→ 0 total
Exercise/Conversion
Outlook Therapeutics, Inc.$OTLK
Warrant (Right to Buy)
2020-01-29$1.00/sh−1,282,051→ 0 total
Exercise/Conversion
Outlook Therapeutics, Inc.$OTLK
Warrant (Right to Buy)
2020-01-29$1.00/sh−1,282,051→ 0 total
Disposition to Issuer
Outlook Therapeutics, Inc.$OTLK
Warrant (Right to Buy)
2020-01-27−2,093,750→ 0 total
Award
Outlook Therapeutics, Inc.$OTLK
Warrant (Right to Buy)
2020-01-27+2,093,750→ 2,039,750 total
Award
Outlook Therapeutics, Inc.$OTLK
Warrant (Right to Buy)
2020-01-27$1.00/sh+1,282,051→ 1,282,051 total
Disposition to Issuer
Outlook Therapeutics, Inc.$OTLK
Warrant (Right to Buy)
2020-01-27$1.00/sh−1,282,051→ 0 total
Award
Outlook Therapeutics, Inc.$OTLK
Warrant (Right to Buy)
2020-01-27$1.00/sh+1,282,051→ 1,282,051 total
Disposition to Issuer
Outlook Therapeutics, Inc.$OTLK
Warrant (Right to Buy)
2020-01-27$1.00/sh−1,282,051→ 0 total
Other
Outlook Therapeutics, Inc.$OTLK
Series A-1 Convertible Preferred Stock
2019-12-31+1,661→ 68,112 total
Exercise/Conversion
Outlook Therapeutics, Inc.$OTLK
Warrant (Right to Buy)
2019-12-23−3,636,364→ 0 total
Exercise/Conversion
Outlook Therapeutics, Inc.$OTLK
Common Stock
2019-12-23$0.23/sh+2,909,091→ 16,948,585 total
Other
Outlook Therapeutics, Inc.$OTLK
Series A-1 Convertible Preferred Stock
2019-09-30+1,620→ 66,451 total
Other
Outlook Therapeutics, Inc.$OTLK
Series A-1 Convertible Preferred Stock
2019-06-30+1,581→ 64,831 total
Exercise/Conversion
Outlook Therapeutics, Inc.$OTLK
Common Stock
2019-06-17+2,181,818→ 14,039,494 total
Exercise/Conversion
Outlook Therapeutics, Inc.$OTLK
Warrant (Right to Buy)
2019-06-17−3,636,364→ 0 total
Award
Outlook Therapeutics, Inc.$OTLK
Common Stock
2019-04-12$2.75/sh+3,636,364→ 11,857,676 total
Award
Outlook Therapeutics, Inc.$OTLK
Warrant (Right to Buy)
2019-04-12+3,636,364→ 3,636,364 total
Award
Outlook Therapeutics, Inc.$OTLK
Warrant (Right to Buy)
2019-04-12+3,636,364→ 3,636,364 total
Other
Outlook Therapeutics, Inc.$OTLK
Series A-1 Convertible Preferred Stock
2019-03-31+1,542→ 63,250 total
Award
Outlook Therapeutics, Inc.$OTLK
Common Stock
2019-02-01$0.93/sh+4,288,624→ 65,770,503 total
Award
Outlook Therapeutics, Inc.$OTLK
Common Stock
2019-01-02$0.93/sh+4,288,624→ 61,481,879 total
Other
Outlook Therapeutics, Inc.$OTLK
Series A-1 Convertible Preferred Stock
2018-12-31+1,505→ 61,708 total
Award
Outlook Therapeutics, Inc.$OTLK
Common Stock
2018-12-03$0.93/sh+4,288,624→ 57,193,255 total
Award
Outlook Therapeutics, Inc.$OTLK
Common Stock
2018-11-07$0.93/sh+8,577,248→ 52,904,631 total
Other
Outlook Therapeutics, Inc.$OTLK
Series A-1 Convertible Preferred Stock
2018-09-30+1,648→ 60,383 total
Other
Outlook Therapeutics, Inc.$OTLK
Series A-1 Convertible Preferred Stock
2018-09-30+1,468→ 60,203 total
Disposition to Issuer
Outlook Therapeutics, Inc.$OTLK
Series A Convertible Preferred Stock
2018-07-18−58,735→ 0 total
Award
Outlook Therapeutics, Inc.$OTLK
Series A-1 Convertible Preferred Stock
2018-07-18+58,735→ 58,735 total
Award
Outlook Therapeutics, Inc.$OTLK
Series A Convertible Preferred Stock
2018-07-18+6,526→ 58,735 total
Conversion
Outlook Therapeutics, Inc.$OTLK
Series A Convertible Preferred Stock
2018-06-20−208,836→ 52,209 total
Conversion
Outlook Therapeutics, Inc.$OTLK
Common Stock
2018-06-20+31,572,617→ 44,327,383 total
Award
Outlook Therapeutics, Inc.$OTLK
Warrants
2018-06-08$0.13/sh+10,256,410→ 20,512,820 total
Award
Outlook Therapeutics, Inc.$OTLK
Common Stock
2018-06-08$0.97/sh+6,377,383→ 12,754,766 total
Award
Outlook Therapeutics, Inc.$OTLK
Common Stock
2018-05-14$0.97/sh+6,377,383→ 6,377,383 total
Award
Outlook Therapeutics, Inc.$OTLK
Warrants
2018-05-14$0.13/sh+10,256,410→ 10,256,410 total
Other
Outlook Therapeutics, Inc.$OTLK
Series A Convertible Preferred Stock
2018-03-31+6,367→ 261,045 total
Other
Outlook Therapeutics, Inc.$OTLK
Series A Convertible Preferred Stock
2017-12-31+4,678→ 254,678 total
Purchase
Outlook Therapeutics, Inc.$OTLK
Series A Convertible Preferred Stock
2017-10-31$100.00/sh+217,372→ 250,000 total
Purchase
Outlook Therapeutics, Inc.$OTLK
Warrants
2017-10-31+16,750,000→ 16,750,000 total

Companies

Outlook Therapeutics, Inc.
Director, 10% Owner
$OTLK

Recent Filings

Address

#30, "GALAXY", 1ST MAIN, J.P. NAGAR, 3RD PHASE,

BANGALORE, K7, 560078

View on SEC.gov